Justin M. Canada
Justin M. Canada
Assistant Professor, Virginia Commonwealth University
Verified email at vcuhealth.org
Cited by
Cited by
Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure
BW Van Tassell, RA Arena, S Toldo, E Mezzaroma, T Azam, IM Seropian, ...
PloS one 7 (3), e33438, 2012
Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)
BW Van Tassell, R Arena, G Biondi-Zoccai, JM Canada, C Oddi, ...
American journal of Cardiology 113 (2), 321-327, 2014
Heart failure with preserved ejection fraction: refocusing on diastole
A Abbate, R Arena, N Abouzaki, BW Van Tassell, JM Canada, K Shah, ...
International journal of cardiology 179, 430-440, 2015
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
BW Van Tassell, JM Canada, S Carbone, C Trankle, L Buckley, CO Erdle, ...
Circulation: Heart Failure 10 (11), e004373, 2017
Exercise blood pressure response during assisted circulatory support: Comparison of the total artifical heart with a left ventricular assist device during rehabilitation
HS Kohli, JM Canada, R Arena, DG Tang, MA Peberdy, S Harton, ...
The Journal of Heart and Lung Transplantation 30 (11), 1207-1213, 2011
Exercise intolerance in patients with heart failure: JACC State-of-the-Art Review
MG Del Buono, R Arena, BA Borlaug, S Carbone, JM Canada, ...
Journal of the American College of Cardiology 73 (17), 2209-2225, 2019
Obesity contributes to exercise intolerance in heart failure with preserved ejection fraction
S Carbone, JM Canada, LF Buckley, CR Trankle, DL Dixon, R Buzzetti, ...
Journal of the American College of Cardiology 68 (22), 2487, 2016
Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2)
BW Van Tassell, LF Buckley, S Carbone, CR Trankle, JM Canada, ...
Clinical cardiology 40 (9), 626-632, 2017
Interleukin-1 blockade in rheumatoid arthritis and heart failure: a missed opportunity?
A Abbate, JM Canada, BW Van Tassell, CM Wise, CA Dinarello
International journal of cardiology 171 (3), e125-e126, 2014
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ...
Circulation: Heart Failure 11 (8), e005036, 2018
Obesity paradox in cardiovascular disease: where do we stand?
S Carbone, JM Canada, HE Billingsley, MS Siddiqui, A Elagizi, CJ Lavie
Vascular health and risk management 15, 89, 2019
Usefulness of canakinumab to improve exercise capacity in patients with long-term systolic heart failure and elevated C-reactive protein
CR Trankle, JM Canada, L Cei, N Abouzaki, C Oddi-Erdle, D Kadariya, ...
The American journal of cardiology 122 (8), 1366-1370, 2018
Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
LF Buckley, JM Canada, MG Del Buono, S Carbone, CR Trankle, ...
ESC heart failure 5 (2), 372-378, 2018
Rationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter study
BW Van Tassell, MJ Lipinski, D Appleton, CS Roberts, MC Kontos, ...
Clinical cardiology 41 (8), 1004-1008, 2018
Usefulness of C-reactive protein plasma levels to predict exercise intolerance in patients with chronic systolic heart failure
JM Canada, DT Fronk, LF Cei, S Carbone, CO Erdle, NA Abouzaki, ...
American Journal of Cardiology 117 (1), 116-120, 2016
Biomarkers of cardiac injury in patients undergoing thoracic radiation therapy
NA Serrano, R Mikkelsen, JM Canada, E Mezzaroma, E Weiss, A Abbate
International journal of cardiology 223, 507-509, 2016
Pharmacologic and surgical interventions to improve functional capacity in heart failure
A Abbate, BW Van Tassell, JM Canada, DL Dixon, RA Arena, ...
Heart failure clinics 11 (1), 117-124, 2015
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics
S Carbone, JM Canada, HE Billingsley, D Kadariya, DL Dixon, ...
Diabetes, Obesity and Metabolism 20 (8), 2014-2018, 2018
Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction
C Trankle, JM Canada, L Buckley, S Carbone, D Dixon, R Arena, ...
ESC heart failure 4 (3), 351-355, 2017
IL-1 blockade reduces inflammation in pulmonary arterial hypertension and right ventricular failure: a single-arm, open-label, phase IB/II pilot study
CR Trankle, JM Canada, D Kadariya, R Markley, HM De Chazal, J Pinson, ...
American journal of respiratory and critical care medicine 199 (3), 381-384, 2019
The system can't perform the operation now. Try again later.
Articles 1–20